Literature DB >> 23524040

LC-MS/MS quantification of a neuropeptide fragment kisspeptin-10 (NSC 741805) and characterization of its decomposition product and pharmacokinetics in rats.

Zhongfa Liu1, Chen Ren, William Jones, Ping Chen, Stephanie B Seminara, Yee-Ming Chan, Nicola F Smith, Joseph M Covey, Jeffrey Wang, Kenneth K Chan.   

Abstract

The kisspeptins are critical regulators of mammalian reproduction. Kisspeptin-10 ((45)YNWNSFGLRF-NH2(54), kisspeptin-112-121 or metastin 45-54, NSC 741805), an active fragment of kisspeptin, has been shown to be a potent stimulator of gonadotropin-releasing hormone and secretion of luteinizing hormone in both rodents and primates. This shorter peptide fragment may have clinical utility potential and it is important to characterize its pharmacokinetic property. Recently, the pharmacokinetics of both kisspeptin-54 and kisspeptin-10 were characterized in humans using a radioimmunoassay (RIA), which measures only the immunoreactive kisspeptin (kisspeptin-IR). In this study, a highly sensitive and specific LC-MS/MS assay was developed to quantify kisspeptin-10 levels in rat plasma. The lower limit of quantitation (LLOQ) was 0.5 ng/mL, the within-day and between-day coefficient of variations (CVs) ranged from 5.2 to 15.4% and 1.3 to 14.2%, and the accuracy values ranged from 98 to 114% and 99 to 105%, respectively. With this method, stability studies demonstrated that kisspeptin-10 degraded rapidly with decomposition half-lives of 6.8 min, 2.9 min and 1.7 min at 4 °C, 25 °C, and 37 °C, respectively. The principal decomposition product was characterized as the N-terminal tyrosine deleted kisspeptin-10 (46)NWDSFGLRF-NH2(54). Pharmacokinetic study in rats showed that low ng/mL kisspeptin-10 was detected in the first few minutes, and eliminated rapidly and became undetectable 30 min after intravenous (i.v.) bolus administration of 1.0 mg/kg kisspeptin-10.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23524040      PMCID: PMC3955120          DOI: 10.1016/j.jchromb.2013.02.027

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  18 in total

1.  Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis.

Authors:  E L Thompson; M Patterson; K G Murphy; K L Smith; W S Dhillo; J F Todd; M A Ghatei; S R Bloom
Journal:  J Neuroendocrinol       Date:  2004-10       Impact factor: 3.627

2.  Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1.

Authors:  J H Lee; D R Welch
Journal:  Cancer Res       Date:  1997-06-15       Impact factor: 12.701

3.  The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54.

Authors:  M Kotani; M Detheux; A Vandenbogaerde; D Communi; J M Vanderwinden; E Le Poul; S Brézillon; R Tyldesley; N Suarez-Huerta; F Vandeput; C Blanpain; S N Schiffmann; G Vassart; M Parmentier
Journal:  J Biol Chem       Date:  2001-07-16       Impact factor: 5.157

4.  Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor.

Authors:  T Ohtaki; Y Shintani; S Honda; H Matsumoto; A Hori; K Kanehashi; Y Terao; S Kumano; Y Takatsu; Y Masuda; Y Ishibashi; T Watanabe; M Asada; T Yamada; M Suenaga; C Kitada; S Usuki; T Kurokawa; H Onda; O Nishimura; M Fujino
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

5.  KiSS-1, a novel human malignant melanoma metastasis-suppressor gene.

Authors:  J H Lee; M E Miele; D J Hicks; K K Phillips; J M Trent; B E Weissman; D R Welch
Journal:  J Natl Cancer Inst       Date:  1996-12-04       Impact factor: 13.506

6.  Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans.

Authors:  Yasuko Horikoshi; Hirokazu Matsumoto; Yoshihiro Takatsu; Tetsuya Ohtaki; Chieko Kitada; Satoshi Usuki; Masahiko Fujino
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

7.  Developmental and hormonally regulated messenger ribonucleic acid expression of KiSS-1 and its putative receptor, GPR54, in rat hypothalamus and potent luteinizing hormone-releasing activity of KiSS-1 peptide.

Authors:  V M Navarro; J M Castellano; R Fernández-Fernández; M L Barreiro; J Roa; J E Sanchez-Criado; E Aguilar; C Dieguez; L Pinilla; M Tena-Sempere
Journal:  Endocrinology       Date:  2004-07-08       Impact factor: 4.736

8.  A role for kisspeptins in the regulation of gonadotropin secretion in the mouse.

Authors:  M L Gottsch; M J Cunningham; J T Smith; S M Popa; B V Acohido; W F Crowley; S Seminara; D K Clifton; R A Steiner
Journal:  Endocrinology       Date:  2004-06-24       Impact factor: 4.736

9.  Peripheral administration of metastin induces marked gonadotropin release and ovulation in the rat.

Authors:  Hisanori Matsui; Yoshihiro Takatsu; Satoshi Kumano; Hirokazu Matsumoto; Tetsuya Ohtaki
Journal:  Biochem Biophys Res Commun       Date:  2004-07-23       Impact factor: 3.575

10.  The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans.

Authors:  Channa N Jayasena; Gurjinder M K Nijher; Alexander N Comninos; Ali Abbara; Adam Januszewki; Meriel L Vaal; Labosshy Sriskandarajah; Kevin G Murphy; Zohreh Farzad; Mohammad A Ghatei; Stephen R Bloom; Waljit S Dhillo
Journal:  J Clin Endocrinol Metab       Date:  2011-10-05       Impact factor: 5.958

View more
  6 in total

1.  Implantation failure in female Kiss1-/- mice is independent of their hypogonadic state and can be partially rescued by leukemia inhibitory factor.

Authors:  Michele Calder; Yee-Ming Chan; Renju Raj; Macarena Pampillo; Adrienne Elbert; Michelle Noonan; Carolina Gillio-Meina; Claudia Caligioni; Nathalie G Bérubé; Moshmi Bhattacharya; Andrew J Watson; Stephanie B Seminara; Andy V Babwah
Journal:  Endocrinology       Date:  2014-05-30       Impact factor: 4.736

2.  Glucagon regulates hepatic kisspeptin to impair insulin secretion.

Authors:  Woo-Jin Song; Prosenjit Mondal; Andrew Wolfe; Laura C Alonso; Rachel Stamateris; Benny W T Ong; Owen C Lim; Kil S Yang; Sally Radovick; Horacio J Novaira; Emily A Farber; Charles R Farber; Stephen D Turner; Mehboob A Hussain
Journal:  Cell Metab       Date:  2014-04-01       Impact factor: 27.287

3.  The KISS1 Receptor as an In Vivo Microenvironment Imaging Biomarker of Multiple Myeloma Bone Disease.

Authors:  Julia Dotterweich; Robert J Tower; Andreas Brandl; Marc Müller; Lorenz C Hofbauer; Andreas Beilhack; Regina Ebert; Claus C Glüer; Sanjay Tiwari; Norbert Schütze; Franz Jakob
Journal:  PLoS One       Date:  2016-05-09       Impact factor: 3.240

4.  Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.

Authors:  Kengo Sato; Remina Shirai; Mina Hontani; Rina Shinooka; Akinori Hasegawa; Tomoki Kichise; Tomoyuki Yamashita; Hayami Yoshizawa; Rena Watanabe; Taka-Aki Matsuyama; Hatsue Ishibashi-Ueda; Shinji Koba; Youichi Kobayashi; Tsutomu Hirano; Takuya Watanabe
Journal:  J Am Heart Assoc       Date:  2017-04-14       Impact factor: 5.501

5.  The pregnant mouse uterus exhibits a functional kisspeptin/KISS1R signaling system on the day of embryo implantation.

Authors:  Mehri Fayazi; Michele Calder; Moshmi Bhattacharya; George A Vilos; Stephen Power; Andy V Babwah
Journal:  Reprod Biol Endocrinol       Date:  2015-09-18       Impact factor: 5.211

6.  Kisspeptin receptor agonist (FTM080) increased plasma concentrations of luteinizing hormone in anestrous ewes.

Authors:  Brian K Whitlock; Joseph A Daniel; Lisa L Amelse; Valeria M Tanco; Kelly A Chameroy; F Neal Schrick
Journal:  PeerJ       Date:  2015-11-05       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.